| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, General Counsel, Corp Sec | SVP, Secretary And GC
2 companies
Colleran David is an EVP, General Counsel, Corp Sec at Anika Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 6 sells.
Estimated insider holdings value: $5.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2022 | ANIK Anika Therapeutics, Inc. | EVP, General Counsel, Corp Sec | Buy | 1,500 | $21.37 | $32,055.00 | +17.9% | +6.4% | +19.4% | |
| Mar 14, 2022 | ANIK Anika Therapeutics, Inc. | EVP, General Counsel, Corp Sec | Buy | 1,500 | $26.65 | $39,978.00 | +21.8% | -19.6% | +5.7% | |
| Apr 2, 2019 | PODD Insulet Corp | SVP, Secretary And GC | Sale+OE | 7,395 | $94.89 | $701,711.55 | -19.5% | - | - | |
| Mar 1, 2019 | PODD Insulet Corp | SVP, Secretary And GC | Sale+OE | 20,975 | $94.65 | $1,985,359.26 | -40.8% | - | - | |
| Feb 5, 2019 | PODD Insulet Corp | SVP, Secretary And GC | Sale+OE | 6,834 | $80.72 | $551,640.48 | -16.7% | - | - | |
| Jan 31, 2019 | PODD Insulet Corp | SVP, Secretary And GC | Sale+OE | 4,826 | $80.00 | $386,080.00 | -12.4% | - | - | |
| Nov 14, 2018 | PODD Insulet Corp | SVP, Secretary And GC | Sale+OE | 6,113 | $80.41 | $491,546.33 | -15.2% | - | - | |
| May 15, 2018 | PODD Insulet Corp | SVP, Secretary And GC | Sell | 4,956 | $86.24 | $427,405.44 | -11.8% | - | - |